4 patents
Utility
Phospholipid Ether Conjugates as Cancer-Targeting Drug Vehicles
2 Mar 23
Disclosed herein are therapeutic compounds capable of targeting abroad range of tumor cells.
Jarrod Longcor, Anatoly Pinchuk, Randall Hoover, Zhongping Huang
Filed: 11 Sep 20
Utility
Luminescent phospholipid analogs for the identification and isolation of circulating tumor cells
11 Oct 22
The present invention is directed to a method of identifying, isolating, and enabling downstream analysis of circulating tumor cells comprising contacting a blood or blood serum sample of a subject with a composition comprising a phospholipid ether analog bound to a luminescent molecule or a magnetic bead and subjecting the blood or blood serum sample of the subject to fluorescent microscopy, flow cytometry or magnetic isolation.
Jamey P. Weichert, Chorom Pak, Anatoly Pinchuk, Kevin Kozak, Marc Longino
Filed: 14 Jun 17
Utility
Phospholipid ether analogs as cancer-targeting drug vehicles
13 Sep 22
The present invention is directed to therapeutic compounds capable of targeting cancer cells and cancer stem cells.
Jamey P. Weichert, Anatoly Pinchuk, Kevin Kozak, Marc Longino, Joseph Grudzinski, Benjamin Titz, Chorom Pak, Nathan Stehle
Filed: 12 Feb 18
Utility
Phospholipid-Flavagline Conjugates and Methods of Using the Same for Targeted Cancer Therapy
3 Jun 21
Disclosed herein are phospholipid ether (PLE) molecules.
Jarrod LONGCOR
Filed: 10 Apr 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first